Suzanne Trudel, MD, MSc Clinician/Research Scientist, Princess Margaret Hospital Assistant Professor, University of Toronto Dr. Suzanne Trudel is an Assistant Professor of Medicine, in the Division of Hematology at the University of Toronto, and a Clinician/Research Scientist in the Department of Medical Oncology and Hematology at Princess Margaret Hospital. Her research focuses on novel drug development for the treatment of multiple myeloma based on molecular targets, and the incorporation of novel treatments into the clinic. Dr. Trudel is a member of the Myeloma Canada Scientific Advisory Boar, a former recipient of the American Society of Hematology Scholar Award and holds a Clinician-Scientist Award from the Canadian Institute of Health Research.
DATE: Thursday, March 25, 2010 TIME: 7:00 pm – 8:00 pm (Eastern) 4:00 pm – 5:00 pm (Pacific) 5:00 pm – 6:00 pm (Mountain) 6:00 pm – 7:00 pm (Central) 8:00 pm – 9:00 pm (Atlantic) 8:30 pm – 9:30 pm (Newfoundland)
Registration is free. To register for the online event ------------------------------------------------------- 1. Go to https://myelomacanada.webex.com/myelomacanada/onstage/g.php?t=a&d=662988212 2. Click Register. 3. On the registration form, enter your information and then click Submit. For online assistance, please contact WebEx Technical Support Phone: Call 1-866-229-3239 (U.S. and Canada toll-free), +1-408-435-7088
The goal of the "Highlights from the ASH Meeting" webinar is to inform patients and caregivers of the latest clinical research findings presented at the annual American Society of Hematology (ASH) meeting held in December.
Funding for this site has been made available by Myeloma Canada